Your browser doesn't support javascript.
loading
Research on the influence of APOBEC family on the occurrence, diagnosis, and treatment of various tumors.
Yang, Jing; Hou, Jiali; Li, Mengxia.
Affiliation
  • Yang J; Department of Oncology, Daping Hospital, Army Medical University, Chongqing, 400042, China.
  • Hou J; School of Sericulture, Textile and Biomass Science, Southwest University, Chongqing, 400715, China.
  • Li M; School of Life Sciences, Chongqing University, Chongqing, 400044, China.
J Cancer Res Clin Oncol ; 149(1): 357-366, 2023 Jan.
Article in En | MEDLINE | ID: mdl-36222899
ABSTRACT

BACKGROUND:

Apolipoprotein B mRNA-editing catalytic polypeptide (APOBEC) is a family of highly efficient cytidine deaminase enzymes. APOBECs have been proven to deaminate cytidine on single-stranded DNA or RNA. Inducing the deamination of cytosine on the target gene into uracil, which exerts a variety of physiological functions, plays an important role in innate immunity, adaptive immunity, and antiviral. As the research progresses, APOBECs have been confirmed to be highly expressed in a variety of tumors, causing abnormal mutations in host genes, leading to inactivation of tumor suppressor genes or activation of proto-oncogenes, and their role in tumor development and as diagnostic and treatment markers gradually be found.

CONCLUSION:

This article will review the mechanism of APOBECs and their impact on tumor occurrence, development, diagnosis, and treatment, and provide a theoretical basis for future tumor treatment.
Subject(s)
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Neoplasms Type of study: Diagnostic_studies Limits: Humans Language: En Journal: J Cancer Res Clin Oncol Year: 2023 Document type: Article Affiliation country: China

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Neoplasms Type of study: Diagnostic_studies Limits: Humans Language: En Journal: J Cancer Res Clin Oncol Year: 2023 Document type: Article Affiliation country: China